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aS1200 EPID (24 arcs). The plans were created in Eclipse 
v13.6, and calculated with the AAA13.6 algorithm.  
For each linac, the dosimetric output was calibrated to 
within 0.3%, and the beam flatness and symmetry was 
confirmed to be within specs (103% and 101%, 
respectively). The two verification systems were 
calibrated according to vendor instructions. Treatment 
plans were verified with PD according to our clinical 
practice, and the same acquired EPID image was analyzed 
with FZ within the SunCHECK software. 
The measured dose was compared to the predicted dose 
using the gamma analysis method with 3 precision levels: 
Γ 3%/3 mm (3% dose difference and 3 mm DTA), Γ 2%/2 
mm and Γ 1%/1 mm (global normalization, dose threshold 
10%). To pass the analysis, the pass rate (points with Γ ≤1) 
should be ≥95% for Γ 3%/3 mm and Γ 2%/2 mm, and ≥90% 
for Γ 1%/1 mm. 
Results 
For both methods and both machines/EPIDs, all arcs 
passed the Γ 3%/3 mm analysis used in clinical routine. 
With stricter criteria, there is a number of arcs where one 
method passes while the other fails, as shown in Figure 1. 
There is a tendency of more arcs passing with FZ than with 
PD.  
 
 
 
The numbers of arcs that pass with one method but fail 
with the other were compared using Pearsons χ2 test under 
the null hypothesis that "FZ pass & PD fail" is equally 
probable to "PD pass & FZ fail". The difference is 
statistically significant for measurements performed with 
Clinac/aS1000, as presented in Table 1.  
 
Table 1: Pearsons χ2 comparison of numbers of arcs that 
pass one method but fail the other  
Precisio
n Level    
Machine/EPID       
  
FZ 
pass 
& PD 
fail    
PD 
pass 
& FZ 
fail    
Significant
? 
Γ 2%/2 
mm Clinac/aS1000         7         1 
Yes (p = 
0,03) 
Γ 1%/1 
mm Clinac/aS1000       23         0 
Yes (p = 
0,00) 
Γ 1%/1 
mm TrueBeam/aS1200         9         4 
No (p = 
0,17) 
 
The average Γ pass rate is higher with FZ than with PD for 
all precision levels (Figure 2), but the difference is not 
statistically significant. However, it’s worth noting that 
most arcs have a higher pass rate with FZ than with PD. 
 
 
 
Conclusion 
Regardless of precision level, there’s no significant 
difference between the average gamma pass rates from 
the two methods. For the criteria used in clinical routine, 
the two methods appear equivalent. 
For the more stringent criteria there is a number of arcs 
where one method passes while the other fails, with a 
tendency of more arcs passing with FZ than with PD. This 
may be caused by the different approach to absolute 
calibration of the EPID. Future work will include 2D 
phantom measurements to determine which method 
corresponds better to the actual dose delivered. 
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Based In-Vivo Dose Verification for Prostate SBRT 
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1Hacettepe University - Oncology Institute, Radiation 
Oncology, ankara, Turkey  
 
Purpose or Objective 
The main purpose was to investigate electronic portal 
imaging based new in-vivo dosimetry tool iViewDose 
(Elekta AB, Stockholm, Sweden) for SBRT prostate cancer 
treatment in clinical use. 
Material and Methods 
The study was performed on Versa HD linear accelerator 
(Elekta AB, Stockholm, Sweden) and feasibility of 
iViewDose Version 1.0.1 tool was analyzed for prostate 
SBRT plans in clinical use. To validate this new quality 
assurance system in clinical facilities, fifteen prostate 
cancer patients were selected and iViewDose based in-
vivo EPID dosimetry was performed. Treatment plans were 
generated with RayStation treatment planning system 
(RaySearch Lab., Stockholm, Sweeden) and dose 
prescribed as 36.5 Gy in five fraction. For all SBRT patient, 
three dimensional gamma analysis results were evaluated. 
Additionally, measured and calculated dose in reference 
point (DRP) for CTV, rectum, bladder and femur heads 
were compared for all fraction. 
Results 
According to measurement results, mean gamma analysis 
(γ%≤1) passing rate of fifteen patient was found as 95.58% 
for γ3D (criteria: 3% global dose difference/3 mm distance 
to agreement, threshold 50%). Additionally, mean DRP 
difference between measurement and calculated in 
treatment planning system for CTV, rectum, bladder, left 
and right femur heads were found as 1.97%, 10.04%, 
18.318%, 3.19% and 4.56%, respectively. Maximum dose 
differences were found in rectum and bladder reference 
point due to the high dose gradient in these region. 
However, in medium and low dose gradient region 
measurements were compatible in 1% with calculated dose 
in treatment planning system. 
Conclusion 
iViewDose EPID-based in vivo dosimetry software provides 
an efficient safety check on the accuracy of dose delivery 
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during radiotherapy facilities. This is especially important 
in SRS/SBRT modalities which employ higher therapeutic 
doses in daily fraction. 
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Purpose or Objective 
MRI-Linacs are a fast-growing area of cancer radiotherapy. 
To date only MRI-Linac photon beams have been 
investigated. However, radiotherapy quality can be 
improved for a wide range of clinical indications by using 
electron beams alone or in combination with photon 
beams. The objective of this work is to investigate the 
dosimetric impact of a magnetic field with different field 
strengths and orientations on therapeutic electron beams 
for three beam energies. For this purpose, an 
experimental setup for measuring dose distributions of 
clinical electron beams generated by a conventional linac 
in the presence of a magnetic field is established. 
Material and Methods 
A permanent magnet device was used to generate a 
magnetic field surrounding a solid water slab phantom. 
The magnetic field including maximal field strength Bmax 
was varied by moving the permanent magnet banks and by 
insertion of focusing steel cones. Electron beams (6, 12 
and 20 MeV) from a clinical linear accelerator (Varian 
Clinac 2100C) were incident perpendicular (transverse 
setup) and parallel (inline setup) to the main magnetic 
field direction. The magnet device was placed at a source 
to isocenter distance of 150 cm and the electron beams 
were collimated to a circle of 1 cm diameter and a square 
of 1.5 cm side length, respectively. Gafchromic EBT3 film 
was placed inside the homogeneous slab phantom, parallel 
to the beam (transverse setup) and perpendicular to the 
beam (inline setup) to measure two-dimensional dose 
distributions. Reference conditions with zero magnetic 
field were established by using identical collimation in an 
aluminum frame setup. 
Results 
As expected, for the transverse setup, substantial 
deflection of the electron beam was observed in the 
magnetic field, as indicated in figure (1). Consequently, a 
shift of lateral dose profiles and shift in distal dose fall-off 
(R50 up to -5 mm) was measured for all three electron 
beam energies. For the inline setup, focusing of electron 
beams was observed in magnetic fields compared to the 
zero field reference setup. An increase of measured dose 
of up to 100% (6 MeV beam, 0 vs. 0.7 T magnetic field) was 
shown, yielding a steeper lateral penumbra for a given 
dose level (FWHM -1.5 mm in 2 cm depth).  
 
 
Conclusion 
Propagating in a magnetic field, substantial deflection 
(transverse setup) and focusing (inline setup) of all 
measured electron beams was observed. The inline setup 
shows steeper lateral penumbra of electron fields and thus 
the potential for enhanced plan quality for electron 
treatments. 
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Purpose or Objective 
PRIMO is a graphical environment for MonteCarlo (MC) 
simulations based on the Dose Planning Method (DPM), a 
fast MC algorithm specifically built for the simulation of 
the deposited dose in radiotherapy. The objective of this 
work was to validate the beams calculated by DPM against 
the ones from our Linac EDGE (Varian) and to compare 
PRIMO with the clinical algorithm Acuros (Varian) and film 
measurements with particular focus on the MLC 
parameters. 
Material and Methods 
In a first phase a full characterization of the 10MV FFF 
beam was performed. Then the 120 HD MLC modeling, 
particularly the Tongue and Groove effect, was 
investigated with two types of tests: static MLC fields in 
different settings and MLC plans configured in ‘dynamic 
fence patterns’. These dynamic tests were planned with 
increasing leaf-ends, gap size and degree of TG effect. 
The dose distributions were measured using the IBA 
MultiCube phantom with GafChromic films positioned 
horizontally at 10cm depth. Finally a set of four clinical 
plans was selected from our database. All VMAT plans 
were optimized with 10MV FFF beam in Eclipse and 
calculated with Acuros. The DICOM files (plan, structures 
and images) were imported in PRIMO. DPM was used to 
calculate dose distribution in patients. The dose 
distributions were compared in terms of gamma analysis 
within BODY and PTV. 
 
 
 
 
 
Results 
Concerning the MLC modelling, static fields showed a good 
agreement between Acuros, PRIMO and film 
measurements, with slight differences in transmitted dose 
(Fig1). The comparison between dose profiles for the 
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